Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Henry Meds vs NowPatient

Henry Meds
Graded #46

Higher grade

vs+11.799999999999997
NowPatient
Graded #217

Lower grade

The verdict

Henry Meds takes it — 77.3/100 to 65.5/100.

Henry Meds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. A flat-fee compounded pioneer — simple, but priced at the higher end of the board now.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueHenry Meds +37
72
35
Dose & formulationNowPatient +13
80
93
Clinical oversightNowPatient +6
80
86
Labs & monitoringHenry Meds +24
78
54
FulfillmentHenry Meds +8
78
70
Contract termsHenry Meds +23
78
55
Henry Meds · left barNowPatient · right bar

The numbers

MetricHenry MedsNowPatient
WeighScore77.3/10065.5/100
GradeC+C
Scorecard rank#46#217
Semaglutide$249/mo$1,349/mo (brand Wegovy)
Tirzepatide$349/mo$1,069/mo (brand Mounjaro, promotional rate)
CoverageMulti-stateCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyYes
Henry Meds

Graded #46 · C+

Strengths

  • Simple flat-fee model
  • Established brand
  • Both molecules

Where it loses points

  • Higher pricing than newer entrants
  • Compounded only
NowPatient

Graded #217 · C

Strengths

  • Free telehealth consultation — you only pay for the medication
  • Brand-name Mounjaro, Wegovy injection, Wegovy oral tablet, and Saxenda all available
  • One of the few platforms offering Wegovy in both injection and oral pill form
  • No compounded options — every drug is FDA-approved brand-name

Where it loses points

  • Cash-pay pricing tracks full brand list price (~$1,000–$1,350/mo)
  • No compounded semaglutide or tirzepatide (usually the cheaper route)
  • State availability determined during intake, not shown upfront
  • Does not offer Foundayo (orforglipron)

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard